Flexion Therapeutics reported $4.98M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adamas Pharmaceuticals ADMS:US 527K 142K
Aerie Pharmaceuticals AERI:US $ 6.18M 0.52M
Ani Pharmaceuticals ANIP:US $ 22.31M 2.33M
Anika Therapeutics ANIK:US $ 17.33M 4.01M
Depomed DEPO:US $ 3.92M 0.04M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Emergent Biosolutions EBS:US $ 227.8M 128.5M
Endo International Ordinary Shares ENDP:US $ 313.43M 23.44M
Esperion Therapeutics ESPR:US $ 1.8M 16K
Flexion Therapeutics FLXN:US $ 4.98M 1.11M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Horizon Pharma HZNP:US $ 201M 100.63M
Insmed INSM:US $ 10.84M 993K
Ironwood Pharmaceuticals IRWD:US $ 0M 0M
JAZZ PHA JAZZ:US $ 119.19M 79M
Johnson & Johnson JNJ:US $ 7587M 551M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
Lannett LCI:US $ 83.35M 2.56M
MacroGenics MGNX:US 22K 5K
Pacira Pharmaceuticals PCRX:US $ 35.25M 3.9M
Perrigo Ordinary Shares PRGO:US $ 632.1M 9.5M
Pfizer PFE:US $ 6992M 2820M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Revance Therapeutics RVNC:US $ 5.43M 1.21M
Teva Pharmaceutical Industries TEVA:US $ 1987M 76M
Zogenix ZGNX:US $ 1.22M 0.55M